首页> 美国卫生研究院文献>The Journal of Infectious Diseases >Disparity in the In Vitro versus In Vivo Regulation of Fibronectin-Binding Proteins by 2 Global Regulators saeRS and sigB in Staphylococcus aureus
【2h】

Disparity in the In Vitro versus In Vivo Regulation of Fibronectin-Binding Proteins by 2 Global Regulators saeRS and sigB in Staphylococcus aureus

机译:金黄色葡萄球菌中2种全局调节剂saeRS和sigB对纤连蛋白结合蛋白的体外与体内调节差异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fibronectin-binding protein A plays an important role in Staphylococcus aureus endovascular infections. We characterized the sigB-saeRS-fnbA expression network with fibronectin binding in vitro and in an experimental infective endocarditis (IE) model using parental strains RN6390 and SH1000 and their respective isogenic saeRS mutants. In contrast to the in vitro data, there was no influence of saeRS on fnbA expression in the IE model, yet ex vivo fibronectin binding was reduced in saeRS mutants. Moreover, as opposed to the in vitro findings, sigB appeared to have a positive rather than a negative effect on saeRS expression within cardiac vegetations.
机译:纤连蛋白结合蛋白A在金黄色葡萄球菌血管内感染中起重要作用。我们在体外和在实验性感染性心内膜炎(IE)模型中使用亲本菌株RN6390和SH1000及其各自的同基因saeRS突变体表征了具有纤连蛋白结合的sigB-saeRS-fnbA表达网络。与体外数据相反,在IE模型中,saeRS对fnbA表达没有影响,但是saeRS突变体中离体纤连蛋白的结合减少。此外,与体外发现相反,sigB似乎对心脏植被内的saeRS表达具有正面而非负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号